BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/19/2019 9:59:03 AM | Browse: 766 | Download: 1805
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 39357
Country Türkiye
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Study
Article Title C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumors group
Manuscript Source Unsolicited Manuscript
All Author List Ömer Komaç, Göksel Bengi, Özgül Sağol and Mesut Akarsu
Funding Agency and Grant Number
Corresponding Author Göksel Bengi, MD, Assistant Professor, Department of Gastroenterology, Dokuz Eylul University Faculty of Medicine, Inciraltı, Izmir 35000, Türkiye. goksel.bengi@deu.edu.tr
Key Words Gastroenteropancreatic neuroendocrine tumors; C-reactive protein; Prognostic factor; Neuroendocrine tumors; Gastrointestinal system
Core Tip Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) constitute a heterogeneous group of tumors with variable clinical presentations, different growth rates and unpredictable prognoses. In our study, we aimed to identify the independent prognostic markers for the patients in the whole GEP-NET group. As a result, it was observed that one of the biochemical parameters, C-reactive protein (CRP) affected the course of the progression in the worst way (particularly if it is > 20 mg/dL). With the need for larger scale and prospective studies, it was suggested that CRP level might be a poor prognostic factor for the entire GEP-NET group.
Publish Date 2019-02-15 09:46
Citation Komaç Ö, Bengi G, Sağol Ö, Akarsu M. C-reactive protein may be a prognostic factor for the whole gastroenteropancreatic neuroendocrine tumors group. World J Gastrointest Oncol 2019; 11(2): 139-152
URL https://www.wjgnet.com/1948-5204/full/v11/i2/139.htm
DOI https://dx.doi.org/10.4251/wjgo.v11.i2.139
Full Article (PDF) WJGO-11-139.pdf
Full Article (Word) WJGO-11-139.docx